Connect with us

Hi, what are you looking for?

Law

Food Recall: FDA and Domega NY International recall custard pie

New York product liability attorney alert: Domega NY International issues recall for FUMA custard pies, citing undeclared milk powder.

07/01/2010 // West Palm Beach, FL, USA // Tara Monks // Tara Monks

New York, NY – The U.S. Food and Drug Administration (FDA) issued a press release Wednesday, June 30, 2010, announcing a voluntary recall initiated by Domega NY International Co. Ltd of Brooklyn. The recall involves FUMA Custard Pies.

According to the press release, the pies may contain undeclared milk powder. The FDA warns that consumers who are allergic to milk products may face the risk of serious or life-threatening injuries if they consume the pies.

The recalled pie is packaged in a 650-gram cardboard box that has 26 individual packages inside. The date code is 2010 02 04AA. The products were made in China and sold in New York.

The recall was issued after it was noticed the manufacturer’s written recipe for FUMA custard pie contained milk powder, which was not declared as an ingredient on the label.

No illnesses were declared in connection with the undeclared milk powder.

The FDA tells customers who purchased the custard pie to return it to the place of purchase. Any questions can be directed to the company at (646) 388-3032.

Media Information:

Address:
Phone: (866) 598-1315
Url: http://TaraMonks.visionsmartnews.com/fda-and-domega-ny-international-recall-custard-pie_1167.html

You May Also Like

Business

State would join dozens of others in enacting legislation based on federal government’s landmark whistleblower statute, the False Claims Act

press release

With a deep understanding of the latest tech, Erbo helps businesses flourish in a digital world.

press release

#Automotive #Carbon #Canister #Market #Projected #Hit #USD New York, US, Oct. 24, 2022 (GLOBE NEWSWIRE) —  According to a comprehensive research report by Market...

press release

Barrington Research Analyst James C.Goss reiterated an Outperform rating on shares of IMAX Corp IMAX with a Price target of $20. As theaters...